Massachusetts Financial Services CO Abiomed Inc Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $24.8 Million - $28.2 Million	-98,936 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $25.1 Million - $32.9 Million	-90,862 Reduced 47.87%	98,936 $28.3 Million
Q4 2018 Feb 08, 2019	BUY	$281.08 - $444.25 $3.53 Million - $5.57 Million	12,545 Added 7.08%	189,798 $61.7 Million
Q3 2018 Oct 25, 2018	BUY	$354.53 - $449.75 $12.2 Million - $15.4 Million	34,284 Added 23.98%	177,253 $79.7 Million
Q2 2018 Jul 30, 2018	BUY	$278.07 - $446.21 $27.7 Million - $44.5 Million	99,780 Added 231.03%	142,969 $58.5 Million
Q1 2018 May 04, 2018	BUY	$192.49 - $295.85 $8.31 Million - $12.8 Million	43,189 New	43,189 $12.6 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.